SAN FRANCISCO--(BUSINESS WIRE)--Counsyl, a health technology company that offers DNA screening for diseases that can impact men, women, and their children, announced today that Ramji Srinivasan, founder and CEO of Counsyl, will present at the 34th Annual J.P. Morgan Healthcare Conference at 9:00 a.m. PT (12:00 p.m. ET), on Tuesday, January 12, 2016, in the Elizabethan Room D at the Westin St. Francis Hotel in San Francisco.
Counsyl is a health technology company that offers DNA screening for men, women, and their children. Their philosophy is simple: focus on diseases where advanced knowledge makes a difference in health outcomes, whether it’s changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead.
The Counsyl team includes an accomplished group of problem-solvers — top engineers, scientists, and designers — who are taking the lead on building the modern clinical laboratory. By using automation technology and software to reimagine the clinical lab, Counsyl has unlocked a scalable platform that generates more meaningful health insights for a fraction of the cost at industry-leading speed. Counsyl pairs this high tech approach with a high touch solution for delivering test results.
Counsyl has screened more than 500,000 patients and served over 8,000 health care professionals in its CLIA-certified, CAP-accredited and NYS CLEP-permitted clinical laboratory. From the purely mechanical to the profoundly human, Counsyl strives to make DNA screening truly accessible to everyone.